Click here to skip navigation

ACCME Accreditation Statement

The American Academy of Pediatrics (AAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The AAP designates this enduring material for a maximum of 12 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The AAP designates this PI CME activity for a maximum of 20  AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This Performance Improvement CME program has been reviewed and is approved for a maximum of 20.00 AAPA Category 1 PI-CME credits by the Physician Assistant Review Panel.  All stages of the activity must be completed for a participant to claim any credit. Approval is valid until May 1, 2017.  Physician Assistants should claim only the credit commensurate with the extent of their participation in the activity. This program was planned in accordance with AAPA's CME Standards. 

This program is approved for 32 NAPNAP CE contact hours of which 1 contain pharmacology (Rx) content, (0 related to psychopharmacology), per the National Association of Pediatric Nurse Practitioners (NAPNAP) Continuing Education Guidelines.




This activity is acceptable for a maximum of 32 credits. These credits can be applied toward the AAP CME/CPD Award available to Fellows and Candidate Members of the AAP.




Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities Grid

The AAP CME program aims to develop, maintain, and improve the competence, skills, and professional performance of pediatricians and pediatric healthcare professionals by providing quality, relevant, accessible, and effective educational experiences that address gaps in professional practice.  The AAP CME program strives to meet participants' educational needs and support their life-long learning with a goal of improving care for children and families. (AAP CME Program Mission Statement, January 2013).

The AAP recognizes that there are a variety of financial relationships between individuals and commercial interests that require review to identify possible conflicts of interest in a CME activity. The “AAP Policy on Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities” is designed to ensure quality, objective, balanced, and scientifically rigorous AAP CME activities by identifying and resolving all potential conflicts of interest prior to the confirmation of service of those in a position to influence and/or control CME content. The AAP has taken steps to resolve any potential conflicts of interest.

All AAP CME activities will strictly adhere to the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support: Standards to Ensure the Independence of CME Activities. In accordance with these Standards, the following decisions will be made free of the control of a commercial interest: identification of CME needs, determination of educational objectives, selection and presentation of content, selection of all persons and organizations that will be in a position to control the content, selection of educational methods, and evaluation of the CME activity.
The purpose of this policy is to ensure all potential conflicts of interest are identified and mechanisms to resolve them prior to the CME activity are implemented in ways that are consistent with the public good. The AAP is committed to providing learners with commercially unbiased CME activities.

Activity Title: GER or GERD? Diagnosis and Management
Activity Location:    Online    
Activity Dates:     May 1, 2014 to May 1, 2017

DISCLOSURE OF FINANCIAL RELATIONSHIPS

All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. *Commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.


 

 

Name/Role

 

Relevant Financial Relationship

(Please indicate Yes, or No)

Name of Commercial Interest(s)*

Please list name(s) of entity

AND

Nature of Relevant Financial Relationship(s)

 

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds excluding mutual funds, Consultant, Other - identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products
AAP CME faculty are required to disclose to the AAP and to learners when they plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an unapproved or “off-label” use of an approved device or pharmaceutical.

 

(Do intend to discuss or Do not intend to discuss)

Benjamin Gold, MD, FACG, FAAP

Course Faculty

Yes

1.

I have a Paid Consultant relationship with Pfizer.
Please note: FDA-appointed long term safety advisory committee for use of Celebrex in pediatric patients

 

2.

I have a Paid Consultant relationship with AstraZeneca.
Please note: Advisor regarding design and interpretation of studies of acid suppression in infants and children

 

3.

I have a Paid Consultant relationship with Takeda.
Please note: Advisor regarding design and interpretation of acid suppression in infants and young children

 

4.

I have a Paid Consultant relationship with Johnson & Johnson.
Please note: FDA appointed Pediatric Advisory Board on long-term safety of biologic agents in pediatric patients with inflammatory bowel disease

 

5.

I have a Paid Consultant relationship with Nestle.
Please note: Advisor and speaker on studies of probiotics, allergy and protein choices in infant nutrition

 

 

 

Do intend to discuss

 

I do intend to discuss an unapproved/investigative use of a commercial product/device and will disclose such references to learners

Use of acid suppression agents in infant populations (<12 months)
Use of acid suppression and prokinetic agents in children with extra-esophageal gastroesophageal reflux disease (respiratory, otolaryngological)

Ivor D Hill, MD, ChB, MD,  FAAP

Course Faculty

No

None

Do not intend to discuss

Jenifer Lightdale, MD, MPH, FAAP 

Course Faculty

No

None

Do not intend to discuss

Amy Manela

Course Reviewer

No

None

Do not intend to discuss

Debra Burrowes, MPH

AAP Staff

No

None

Do not intend to discuss

Linda O’Brien

AAP Staff

No

None

Do not intend to discuss

Cathy Schmitt, RN, MA, EdD

Instructional Design Consultant

No

None

Do not intend to discuss

 

Commercial Supporters

The EQIPP: GER or GERD? Diagnosis and Management course was produced by the American Academy of Pediatrics.  No commercial support was provided.


Product-Specific Advertising

No product-specific advertising of any type appears in this activity.  No links to product websites appear in this activity.

 

List of Principal Faculty and Credentials

Benjamin Gold, MD, FACG, FAAP

Ivor D Hill, MD, ChB, MD,  FAAP

Jenifer Lightdale, MD, MPH, FAAP 

 

AAP Staff:

Linda O’Brien

Debra Burrowes, MPH

 

Instructional Designer:

Cathy Schmitt, RN, MA, EdD

 

Name of Medium or Combination of Media Used

Internet course

 

Method of physician participation in the learning process

The EQIPP: GER or GERD? Diagnosis and Management course requires you to do some work online and some offline. The online work involves reviewing the content presentation, researching linked information, and participating in guided activities. The offline work includes the performance improvement activities you will do within your own practice to improve key activities in your practice.

Please note:  CME credit is only awarded to learners who enter and analyze data.  Using sample data provided by EQIPP will exclude learners from receiving AMA Category 1 Credit for the performance improvement activity portion of the course.

 

Estimated time to complete the educational activity

You may progress through the course at a pace that is comfortable for you, taking into consideration the demands of your practice. But it is important to establish a goal for completion. The amount of time you are likely to spend per clinical content area can vary depending on if you pursue additional links for more learning. You may also want to consider some elapsed time between sections to “catch your breath.”


Completion requirements for the Performance Improvement activity include:

  1. Enter baseline data and analyze your results.
  2. Create an improvement plan that has a minimum of 1 aim statement.
  3. Document a minimum of 1 idea for change
  4. Enter data for a minimum of two follow up data sets and analyze your results.
  5. Submit a course evaluation.

Generally speaking, the course can be completed within 4-8 months, depending on the number of improvement cycles you make to reach the goals you have set for your practice.

American Board of Pediatrics Maintenance of Certification Requirements

The American Board of Pediatrics requires two data cycles to meet MOC requirements.  A data cycle consists of Baseline data entry, an improvement plan, an idea for change, and followup data entry.  

Dates of Original Release and Most Recent Review or Revision

This course was launched on May 1, 2014 

Termination Date

This course will remain online until May 1, 2017.  It will no longer be certified for credit after May 1, 2017. 

List of Hardware/Software Requirements

Recommended browsers:

  • Internet Explorer 7.0 and above
  • Firefox 3.0 and above
  • Safari 5.0 and above

Recommended browser settings:

  • JavaScript enabled
  • Cookies enabled
  • SSL 2.0 & SSL 3.0 enabled
  • Flash Player Plug-in (version 7.0 +)
  • Adobe Reader Plug-in (version 6.0 +)

Provider Contact information

If you have questions about this course or encounter technical problems, please contact PediaLink at [email protected].
Email: [email protected]  Subject: EQIPP: GER or GERD? Diagnosis and Management

 

Privacy and Confidentiality Statement

At the American Academy of Pediatrics, we take the issue of privacy very seriously. We do not sell, distribute, barter, or transfer personally identifiable information obtained from a user to a third party. Any information collected on the Web site is only used for the purpose stated.

The AAP list is only for important Academy communications, and your e-mail address will not be sold or provided to third parties. You will not receive advertising or promotional material on this list.

The American Academy of Pediatrics may use "cookie" technology to obtain non-personal information from its online visitors. We do not extract personal information in this process nor do we provide this information to third parties. We also do not contact you based on information in your cookie file.

The American Academy of Pediatrics has taken steps to make all information received from our online visitors as secure as possible against unauthorized access and use. All information is protected by our security measures, which are periodically reviewed.